Clinical Routine Application of the Second-generation Neuroendocrine Markers ISL1, INSM1, and Secretagogin in Neuroendocrine Neoplasia: Staining Outcomes and Potential Clues for Determining Tumor Origin
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical Routine Application of the Second-generation Neuroendocrine Markers ISL1, INSM1, and Secretagogin in Neuroendocrine Neoplasia: Staining Outcomes and Potential Clues for Determining Tumor Origin
Authors
Keywords
-
Journal
ENDOCRINE PATHOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-08-19
DOI
10.1007/s12022-020-09645-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Diagnostic Value of Insulinoma-Associated Protein 1 (INSM1) and Comparison With Established Neuroendocrine Markers in Pulmonary Cancers: A Comprehensive Study and Review of the Literature
- (2020) Johan Staaf et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Long Non-coding RNAs in Pulmonary Neuroendocrine Neoplasms
- (2020) Damodaran Narayanan et al. ENDOCRINE PATHOLOGY
- 20 Years of Secretagogin: Exocytosis and Beyond
- (2019) Magdalena Maj et al. Frontiers in Molecular Neuroscience
- INSM 1 Expression in Primary and Metastatic Neuroendocrine Neoplasms of the Gastrointestinal and Pancreatobiliary Tracts
- (2019) Iván González et al. HISTOPATHOLOGY
- INSM1 is a Sensitive and Specific Marker of Neuroendocrine Differentiation in Head and Neck Tumors
- (2018) Lisa M. Rooper et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Immunohistochemical Biomarkers of Gastrointestinal, Pancreatic, Pulmonary, and Thymic Neuroendocrine Neoplasms
- (2018) Silvia Uccella et al. ENDOCRINE PATHOLOGY
- Insulinoma-associated protein 1 is a novel sensitive and specific marker for small cell carcinoma of the prostate
- (2018) Wei Xue et al. HUMAN PATHOLOGY
- INSM1 is More Sensitive and Interpretable than Conventional Immunohistochemical Stains Used to Diagnose Merkel Cell Carcinoma
- (2018) Mohammed T. Lilo et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- The expression of TTF1, CDX2 and ISL1 in 74 poorly differentiated neuroendocrine carcinomas
- (2018) Hwajeong Lee et al. Annals of Diagnostic Pathology
- Insulinoma-associated protein 1 (INSM1) is a sensitive and highly specific marker of neuroendocrine differentiation in primary lung neoplasms: an immunohistochemical study of 345 cases, including 292 whole-tissue sections
- (2018) Sanjay Mukhopadhyay et al. MODERN PATHOLOGY
- Molecular Profiling of Pheochromocytoma and Abdominal Paraganglioma Stratified by the PASS Algorithm Reveals Chromogranin B as Associated With Histologic Prediction of Malignant Behavior
- (2018) Adam Stenman et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Insulinoma-associated protein 1 expression in pancreatic neuroendocrine tumours in endoscopic ultrasound-guided fine-needle aspiration cytology: An analysis of 14 patients
- (2018) Yorihiko Takase et al. CYTOPATHOLOGY
- Insulinoma-associated protein 1 immunostaining on cytology specimens: an institutional experience
- (2018) Erika F. Rodriguez et al. HUMAN PATHOLOGY
- A new marker, insulinoma-associated protein 1 (INSM1), for high-grade neuroendocrine carcinoma of the uterine cervix: Analysis of 37 cases
- (2017) Shiho Kuji et al. GYNECOLOGIC ONCOLOGY
- Isl1 mediates mesenchymal expansion in the developing external genitalia via regulation of Bmp4, Fgf10 and Wnt5a
- (2017) Saunders T Ching et al. HUMAN MOLECULAR GENETICS
- Insulinoma-associated protein 1 (INSM1) is a useful marker for pancreatic neuroendocrine tumor
- (2017) Masahiko Tanigawa et al. Medical Molecular Morphology
- INSM1: A Novel Immunohistochemical and Molecular Marker for Neuroendocrine and Neuroepithelial Neoplasms
- (2015) Jason N. Rosenbaum et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Islet-1 Is a Sensitive But Not Entirely Specific Marker for Pancreatic Neuroendocrine Neoplasms and Their Metastases
- (2013) Rondell P. Graham et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- ISL1 expression is not restricted to pancreatic well-differentiated neuroendocrine neoplasms, but is also commonly found in well and poorly differentiated neuroendocrine neoplasms of extrapancreatic origin
- (2013) Abbas Agaimy et al. MODERN PATHOLOGY
- Hormonally defined pancreatic and duodenal neuroendocrine tumors differ in their transcription factor signatures: expression of ISL1, PDX1, NGN3, and CDX2
- (2011) Gratiana Hermann et al. VIRCHOWS ARCHIV
- Islet 1 (Isl1) Expression is a Reliable Marker for Pancreatic Endocrine Tumors and Their Metastases
- (2009) Anja M. Schmitt et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now